Chronic News and Research

RSS

Acute kidney injury on the rise in hospitalized pregnant women

A study presented at ASN Kidney Week 2019 (November 5 to November 10) shows that the rate of acute kidney injury (AKI) is rising among US women who are hospitalized in pregnancy. The highest risk is in pregnant diabetic women. Women who suffer acute damage to the kidney while pregnant have 260 times the risk of death while in hospital compared to other pregnant women, at 2.6% vs 0.01%. Both mother and baby are at risk of increased illness and death if the woman has kidney injury during pregnancy.

11 Nov 2019

Lupus flare-ups could be linked to environmental factors

Researchers have found that alteration in the environment and atomospheric factors could be associated with organ specific flare-ups of lupus among patients diagnosed with Systemic Lupus Erethematosus (SLE). The study results were presented at the 2019 ACR/ARP Annual Meeting. The abstract was titled, “Environmental and Atmospheric Factors in Systemic Lupus Erythematosus: A Regression Analysis.”

11 Nov 2019

Negative spousal exchanges can have major impact on caregiving couples

A spouse requiring caregiving for chronic illness or a disability can create a stressful environment for married couples.

11 Nov 2019

Groundwork laid for new kind of neural interface system

By electrically stimulating nerves, neuromodulation therapies can reduce epileptic seizures, soothe chronic pain, and treat depression and a host of other health conditions without the use of conventional drugs like opioids.

11 Nov 2019

Chronic sleep deprivation linked to increased biological aging and cardiovascular disease risk

Getting a good night's sleep is important and insufficient sleep has been linked to poor health in many studies.

11 Nov 2019

Australian women with endometriosis turning to cannabis to alleviate symptoms

A new study published today in Journal of Obstetrics Gynaecology Canada has found one in eight Australian women with endometriosis use cannabis to alleviate pain and other symptoms, rating the plant based medicine as the most effective way to self-manage the disorder.

11 Nov 2019

Artistic activities from a young age can reduce social inequalities, encourage healthy behaviors

Engaging in artistic activities such as singing and dancing from a young age can reduce social inequalities and encourage healthy behaviors, according to a new report from UCL and the World Health Organization.

11 Nov 2019

Gadolinium-enhanced MRI of shoulders helps predict recurrence of polymyalgia rheumatica

According to new research findings presented this week at the 2019 ACR/ARP Annual Meeting, use of gadolinium-enhanced magnetic resonance imaging (MRI) in shoulders of patients with polymyalgia rheumatica may contribute to more accurate diagnosis and prediction of recurrence.

11 Nov 2019

Monash researchers create nanoparticle for improving properties of painkillers

Researchers at the Monash Institute of Pharmaceutical Sciences and the ARC Centre of Excellence in Convergent Bio-Nano Science and Technology have created a nanoparticle that could improve the properties of painkillers by delivering them directly to the source of pain.

11 Nov 2019

Cancer patients with RA treated with immune checkpoint inhibitors likely to experience a flare

A new study found that cancer patients with a pre-existing autoimmune disease receiving immune checkpoint inhibitors as treatment are likely to experience a flare.

11 Nov 2019

Research highlights benefits of oral prednisolone in patients with hand osteoarthritis

Research presented at the 2019 ACR/ARP Annual Meeting found that a six-week treatment with low-dose oral prednisolone substantially improves pain and decreases signs of inflammation in patients with painful hand osteoarthritis.

11 Nov 2019

Opioids do not improve quality of life or depression in OA patients

New research presented at the 2019 ACR/ARP Annual Meeting suggests that opioids contribute no measurable benefit to quality of life or depression for patients with osteoarthritis (OA).

11 Nov 2019

Psoriasis onset determines whether arthritis or psoriasis starts first in people with psoriatic arthritis

In a new study presented at the 2019 ACR/ARP Annual Meeting, researchers found that the age of psoriasis onset determines whether arthritis or psoriasis starts first in people with psoriatic arthritis.

11 Nov 2019

Tocilizumab more effective than rituximab in achieving low disease activity in RA patients

New research discovered that tocilizumab is more effective than rituximab in achieving low disease activity in patients with rheumatoid arthritis whose synovial tissue show a low level of B cell infiltration and did not respond to conventional synthetic disease-modifying anti-rheumatic drugs (conventional synthetic DMARDs) or tumor necrosis factor inhibitors first.

11 Nov 2019

Study shows ADA2 is a sensitive, specific biomarker for macrophage activation syndrome

According to new research findings presented at the 2019 ACR/ARP Annual Meeting, adenosine deaminase 2 (ADA2) in the peripheral blood is a sensitive, specific biomarker for macrophage activation syndrome, a potentially life-threatening complication of systemic juvenile idiopathic arthritis (systemic JIA)

10 Nov 2019

Study provides first data on infectious risk in children exposed to non-TNFi biologics and tofacitinib

A new study found that very few serious infections were seen in children born to mothers with chronic inflammatory diseases who used non-TNFi biologics or tofacitinib during pregnancy compared to children not exposed to these drugs and children exposed to TNFi biologics in utero.

10 Nov 2019

Biologics can be used effectively for both elderly-onset and young-onset RA patients

According to new research findings presented this week at the 2019 ACR/ARP Annual Meeting, both patients with rheumatoid arthritis whose disease onset occurred at an older age and those whose disease onset occurred earlier in life have similar improvements in clinical disease at 48 weeks after starting biologic disease-modifying antirheumatic drugs, as well as similar drug maintenance and adverse events discontinuation rates.

10 Nov 2019

Additional medications needed to control the symptoms of juvenile idiopathic arthritis

According to new research findings presented this week at the 2019 ACR/ARP Annual Meeting, there is a profound ongoing need for additional medications to control the signs and symptoms of juvenile idiopathic arthritis, despite the availability of several approved biologic disease-modifying antirheumatic drugs (biologics).

10 Nov 2019

Atmospheric and environmental changes linked to organ-specific lupus flares

New research findings presented at the 2019 ACR/ARP Annual Meeting found a strong association between changes in atmospheric and environmental variables 10 days before a clinic visit and organ-specific lupus flares in patients with systemic lupus erythematosus.

10 Nov 2019

Children with Down syndrome at greater risk of an associated form of arthritis

A new study finds that children with Down syndrome are at an increased risk of an associated form of arthritis.

10 Nov 2019

Chronic News and Research

Acute kidney injury on the rise in hospitalized pregnant women

Lupus flare-ups could be linked to environmental factors

Negative spousal exchanges can have major impact on caregiving couples

Groundwork laid for new kind of neural interface system

Chronic sleep deprivation linked to increased biological aging and cardiovascular disease risk

Australian women with endometriosis turning to cannabis to alleviate symptoms

Artistic activities from a young age can reduce social inequalities, encourage healthy behaviors

Gadolinium-enhanced MRI of shoulders helps predict recurrence of polymyalgia rheumatica

Monash researchers create nanoparticle for improving properties of painkillers

Cancer patients with RA treated with immune checkpoint inhibitors likely to experience a flare

Research highlights benefits of oral prednisolone in patients with hand osteoarthritis

Opioids do not improve quality of life or depression in OA patients

Psoriasis onset determines whether arthritis or psoriasis starts first in people with psoriatic arthritis

Tocilizumab more effective than rituximab in achieving low disease activity in RA patients

Study shows ADA2 is a sensitive, specific biomarker for macrophage activation syndrome

Study provides first data on infectious risk in children exposed to non-TNFi biologics and tofacitinib

Biologics can be used effectively for both elderly-onset and young-onset RA patients

Additional medications needed to control the symptoms of juvenile idiopathic arthritis

Atmospheric and environmental changes linked to organ-specific lupus flares

Children with Down syndrome at greater risk of an associated form of arthritis

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News